Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 215813
Company: AVYXA HOLDINGS
Company: AVYXA HOLDINGS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DOCETAXEL | DOCETAXEL | 160MG/16ML | INJECTABLE;INJECTION | Prescription | None | No | No |
DOCIVYX | DOCETAXEL | 20MG/2ML (10MG/ML) | SOLUTION;INTRAVENOUS | Prescription | None | Yes | Yes |
DOCIVYX | DOCETAXEL | 80MG/8ML (10MG/ML) | SOLUTION;INTRAVENOUS | Prescription | None | Yes | Yes |
DOCIVYX | DOCETAXEL | 160MG/16ML (10MG/ML) | SOLUTION;INTRAVENOUS | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/22/2022 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215813s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215813Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/215813Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/11/2024 | SUPPL-2 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215813s001s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/215813Orig1s001; s002ltr.pdf | |
04/11/2024 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215813s001s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/215813Orig1s001; s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/11/2024 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215813s001s002lbl.pdf | |
04/11/2024 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215813s001s002lbl.pdf | |
04/11/2024 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215813s001s002lbl.pdf | |
11/22/2022 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215813s000lbl.pdf |